Courtagen Life Sciences, Inc. Announced Today The Launch Of Two New Next Generation DNA Sequencing Tests For Neurodevelopmental Disorders, Developmental Delay, Intellectual Disability, And Autism Spectrum Disorders

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., an innovative molecular information company, announced today the release of the devSEEK™ Sequence Analysis for Neurodevelopmental Disorders Panel and the devACT™ Clinical Management Panel.

Help employers find you! Check out all the jobs and post your resume.

Back to news